71 related articles for article (PubMed ID: 2943690)
1. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
Pola P; Flore R; Tondi P
Int J Tissue React; 1986; 8(4):333-6. PubMed ID: 2943690
[TBL] [Abstract][Full Text] [Related]
2. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
Weinrauch LA; Gleason RE; Keough J; D'Elia JA
Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
4. [Study of blood viscosity and fibrinogen as a guide to the therapy of atherosclerotic peripheral arteriopathy].
Savi I; Pola P
Minerva Med; 1978 Dec; 69(63):4401-10. PubMed ID: 745806
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
6. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
7. Changes in blood viscosity with the recombinant tissue plasminogen activator alteplase.
Hitosugi M; Omura K; Yufu T; Kido M; Niwa M; Nagai T; Tokudome S
Thromb Res; 2007; 120(3):447-50. PubMed ID: 17064755
[TBL] [Abstract][Full Text] [Related]
8. Rheological and clotting changes in the immediate post-myocardial infarction period.
Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609
[TBL] [Abstract][Full Text] [Related]
9. [Increase in erythrocyte and plasma viscosity in patients with atherosclerotic vasculopathy of different sites].
Craveri A; Tornaghi G; Paganardi L; Di Bella M; Gallo E; Stanzani M
Minerva Med; 1987 Jun; 78(12):815-22. PubMed ID: 3601129
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinolytic and defibrinogenation therapy].
Mannucci PM; Mari D
Ric Clin Lab; 1983; 13 Suppl 3():245-55. PubMed ID: 6672998
[TBL] [Abstract][Full Text] [Related]
11. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
[TBL] [Abstract][Full Text] [Related]
12. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
13. [Incidence of reduced fibrinolytic activity and fibrinogen increase in the pathogenesis of vascular risk in obese subjects. Study of fibrinolytic activity of plasma, fibrinogen, erythrocyte aggregation and plasma viscosity].
Craveri A; Tornaghi G; Paganardi L; Ranieri R; di Bella M
Minerva Cardioangiol; 1988 Nov; 36(11):563-7. PubMed ID: 3244424
[No Abstract] [Full Text] [Related]
14. [Effect of balneotherapeutic measures on blood rheologic parameters in patients with atherosclerosis].
Winkler R; Klieber M
Wien Klin Wochenschr; 1986 Aug; 98(15):490-5. PubMed ID: 3765637
[TBL] [Abstract][Full Text] [Related]
15. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing blood viscosity: adult and newborn blood analysis.
Yamarat P; Sanghirun C; Chantachum Y; Cheeramakara C; Thanomsak W
Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():75-8. PubMed ID: 11414464
[TBL] [Abstract][Full Text] [Related]
17. [The progress of a fibrinolytic therapy with streptokinase, urokinase and warfarin in a thoroughbred with intermittent lameness with special reference to resonance thrombography].
Pause B; Nolte I; Geiss V; Mayer H; Lasch HG
Tierarztl Prax; 1988; 16(4):377-83. PubMed ID: 3222790
[TBL] [Abstract][Full Text] [Related]
18. Blood viscosity studies in native and reconstituted polycythemic blood.
Procidano M; Zanolli FA; Fornasiero L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):671-80. PubMed ID: 6083942
[TBL] [Abstract][Full Text] [Related]
19. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
20. [Fibrinolytic treatment today].
Bartolo M; Antignani PL; Ceccarelli V; Murgiano GA; Todini AR
Clin Ter; 1985 Sep; 114(5):371-9. PubMed ID: 2932278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
